ArticleFrontiers in neurology2013
The management of orthostatic hypotension in Parkinson's disease.
Article in Frontiers in neurology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 58 citations in OpenAlex.
- Enhanced Exercise Therapy in Parkinson's disease: A comparative effectiveness trial.Journal of science and medicine in sport · 2016Trial
- Treadmill gait training improves baroreflex sensitivity in Parkinson's disease.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2014Trial
- Enhancing Cardiovascular Autonomic Regulation in Parkinson's Disease Through Non-Invasive Interventions.Life (Basel, Switzerland) · 2025Review
- Levodopa: From Biological Significance to Continuous Monitoring.ACS sensors · 2024Review
- Autoimmunity in Syndromes of Orthostatic Intolerance: An Updated Review.Journal of personalized medicine · 2024Review
- Machine-learning model for the prediction of acute orthostatic hypotension after levodopa administration.CNS neuroscience & therapeutics · 2024Article
- Adverse Events of Physiotherapy Interventions in Parkinsonian Patients.Movement disorders clinical practice · 2022Article
- Rasagiline does not exacerbate autonomic blood pressure dysregulation in early or mild Parkinson's disease.Clinical parkinsonism & related disorders · 2022Article
- Treatment strategies for clozapine-induced hypotension: a systematic review.Therapeutic advances in psychopharmacology · 2022Review
- Ropinirole-Associated Orthostatic Hypotension as Cause of a Prescribing Cascade in an Elderly Man.Cureus · 2021Article
- Regional analysis of cerebral hemodynamic changes during the head-up tilt test in Parkinson's disease patients with orthostatic intolerance.Neurophotonics · 2020Article
- Nocturnal blood pressure changes in Parkinson's disease: correlation with autonomic dysfunction and vitamin D levels.Acta neurologica Belgica · 2020Article
- Clinical Impact of Deep Brain Stimulation on the Autonomic System in Patients with Parkinson's Disease.Movement disorders clinical practice · 2020Review
- Simultaneous electrochemical detection of levodapa, paracetamol and l-tyrosine based on multi-walled carbon nanotubes.RSC advances · 2020Article
- Cerebral hemodynamic monitoring of Parkinson's disease patients with orthostatic intolerance during head-up tilt test.Neurophotonics · 2020Article
- Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson's disease.Journal of neuroinflammation · 2019Article
- Prevalence and Clinical Characteristics of Probable REM Behavior Disorder in Thai Parkinson's Disease Patients.Parkinson's disease · 2018Article
- Editorial: Autonomic Neuropathy and Cardiovascular Disease in Aging.The journal of nutrition, health & aging · 2018Article
- Rotigotine in Combination with the MAO-B Inhibitor Selegiline in Early Parkinson's Disease: A Post Hoc Analysis.Journal of Parkinson's disease · 2016Article
- Treatment of advanced Parkinson's disease.Current opinion in neurology · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Orthostatic hypotension (OH) is a common and disabling symptom affecting Parkinson's disease (PD) patients. We present the effect of the different therapies commonly used to manage PD on this clinical manifestation. For this purpose, we describe the relationship between OH and the current treatments employed in PD, such as L-DOPA, dopaminergic agonists, and continuous dopaminergic stimulation therapies. Additionally, we review the therapeutic measures that could be used to ameliorate OH. There are different approaches to deal with this manifestation, including pharmacological and non-pharmacological treatments, although none of them is specifically aimed for treating OH in PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.